Manni Mohyuddin

healthcare.utah.edu

1 Follower

community-curated profile

Cancer doctor at @huntsmancancer with interest in myeloma, supportive care, end of life, cost-effective/evidence-based care and med-ed. No COI. Views own.

Overview Posts Content Recommendations

Tweet Jan 6, 2023

Now that horse is out of the barn... a few important points about KARMMA-3 #mmsm @paurotero @NBahlis @MyelomaTeacher #myeloma 1/X - First randomized phase 3 trial to show clinical benefit for Car-T cell therapy in MM. That is HUGE. twitter.com/Rahul

by Luciano J Costa

Recommended by 1 person

1 mention by Manni Mohyuddin

Tweet Jan 24, 2023

Results of ALLO-715, an allogeneic BCMA-targeting CAR T cell therapy are published. Novel features to this product: ‼️ Has rituximab kill switch ‼️ Knockout of the T cell receptor alpha constant (TRAC) to reduce GVHD risk ‼️ Knockout CD52 /1 #mmsm w

by Ben Derman

Recommended by 1 person

1 mention by Manni Mohyuddin

Podcast episode Jan 18, 2023

Episode 043: Myeloma Series, Pt.4 - Myeloma Pharmacology

by Kelley Louise Julian and 3 others

Recommended by 1 person

1 mention by Manni Mohyuddin

Tweet Jan 21, 2023

Although a negative trial, the recently published Vorinostat-Len (VR) vs Len (R) analysis of Myeloma XI RCT had some important learning points🧵#mmsm @profghjackson @DrGarethMorgan1 tinyurl.com/ysxu446k

by Raj Chakraborty

Recommended by 1 person

1 mention by Manni Mohyuddin

Paper

Sequencing anti-BCMA therapies in myeloma

by Mohamad Mohty

Recommended by 1 person

1 mention by Manni Mohyuddin

Paper

Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma

by Luciano J Costa

Recommended by 1 person

1 mention by Manni Mohyuddin

Paper

Medicine and Risk Transfer

by Nassim Nicholas Taleb

Recommended by 1 person

1 mention by Manni Mohyuddin

Podcast episode Dec 21, 2022

ASH22 Recap: Lymphoma and CLL

by Raj Chakraborty and 2 others

Recommended by 1 person

1 mention by Manni Mohyuddin

Tweet Dec 5, 2022

Dietary research in blood cancers is an unmet need. Excited that #ASH22 has a special scientific symposium dedicated to Building Dietary Evidence for Hematologic Malignancies this year! Hope you can attend @ASH_hematology @MSKCancerCenter #diet #mmsm

by Urvi Shah

Recommended by 1 person

1 mention by Manni Mohyuddin